Pulmonary Embolism in Covid-19 Pandemic: A Threat to Recovery of the Infected Patients

被引：3

作者：

Obeagu, Emmanuel Ifeanyi ^{[1
]}

Babar, Quratulain ^{[2
]}

Vincent, C. C. N. ^{[3
]}

Okafor, Chukwuma J. ^{[4
]}

Eze, Richard ^{[5
]}

Chijioke, Udunma Olive ^{[6
]}

Ibekwe, Adaobi Maryann ^{[7
]}

Uduchi, Immaculata Ogochukwu ^{[8
]}

机构：

[1] Imo State Univ, Dept Med Lab Sci, Owerri, Nigeria

[2] Govt Coll Univ, Dept Biochem, Faisalabad, Pakistan

[3] Imo State Univ, Dept Nursing Sci, Owerri, Nigeria

[4] State Univ Zanzibar, Dept Pathol & Biochem, Zanzibar, Tanzania

[5] Madonna Univ Nigeria, Dept Med Lab Sci, Elele Campus, Okigwe, Rivers State, Nigeria

[6] Univ Nigeria, Fac Hlth Sci, Dept Hlth Adm & Management, Enugu Campus, Nsukka, Enugu, Nigeria

[7] Nnamdi Azikiwe Univ, Dept Nursing Sci, Nnewi Campus, Nnewi, Anambra, Nigeria

[8] Nnamdi Azikiwe Univ, Dept Med Lab Sci, Nnewi Cmpus, Nnewi, Anambra, Nigeria

来源：

JOURNAL OF PHARMACEUTICAL RESEARCH INTERNATIONAL | 2021年 / 33卷 / 42A期

关键词：

Pulmonary embolism; Covid; 19; pandemic; haemostasis; threat to recovery; VENOUS THROMBOEMBOLISM; D-DIMER; PNEUMONIA; COMPLICATIONS; HEMOSTASIS; MANAGEMENT;

D O I：

10.9734/JPRI/2021/v33i42A32388

中图分类号：

R9 [药学];

学科分类号：

1007 ;

摘要：

Severe Acute Respiratory Syndrome Coronavirus 2 is a new type of coronavirus that can cause Coronavirus Disease 2019 (Covid-19) and is associated with an increased risk of thrombosis-related pulmonary embolism. Globally, doctors have revised their management strategies for suspected and confirmed PD in patients with Coronavirus disease (Covid-19) in 2019. Choosing the right drug and the right dose requires consideration of potential comorbidities, which can be explained by the direct and indirect pathological consequences of Covid-19, complement activation, cytokine release, endothelial dysfunction, and the interaction between different types of blood cells. Discuss the pathophysiological events, therapeutic mortality strategies, risk factors and clinical management of patients with Covid-19 pulmonary embolism.

引用

收藏

页码：90 / 98

页数：9

相关论文

共 66 条

[21] High risk of thrombosis in patients with severe SARS-CoV-2 infection: a multicenter prospective cohort study [J].

Helms, Julie ;

Tacquard, Charles ;

Severac, Francois ;

Leonard-Lorant, Ian ;

Ohana, Mickael ;

Delabranche, Xavier ;

Merdji, Hamid ;

Clere-Jehl, Raphael ;

Schenck, Malika ;

Fagot Gandet, Florence ;

Fafi-Kremer, Samira ;

Castelain, Vincent ;

Schneider, Francis ;

Grunebaum, Lelia ;

Angles-Cano, Eduardo ;

Sattler, Laurent ;

Mertes, Paul-Michel ;

Meziani, Ferhat .

INTENSIVE CARE MEDICINE, 2020, 46 (06) :1089-1098

[22] Hematologic, biochemical and immune biomarker abnormalities associated with severe illness and mortality in coronavirus disease 2019 (COVID-19): a meta-analysis [J].

Henry, Brandon Michael ;

de Oliveira, Maria Helena Santos ;

Benoit, Stefanie ;

Plebani, Mario ;

Lippi, Giuseppe .

CLINICAL CHEMISTRY AND LABORATORY MEDICINE, 2020, 58 (07) :1021-1028

[23] SARS-CoV-2 Cell Entry Depends on ACE2 and TMPRSS2 and Is Blocked by a Clinically Proven Protease Inhibitor [J].

Hoffmann, Markus ;

Kleine-Weber, Hannah ;

Schroeder, Simon ;

Krueger, Nadine ;

Herrler, Tanja ;

Erichsen, Sandra ;

Schiergens, Tobias S. ;

Herrler, Georg ;

Wu, Nai-Huei ;

Nitsche, Andreas ;

Mueller, Marcel A. ;

Drosten, Christian ;

Poehlmann, Stefan .

CELL, 2020, 181 (02) :271-+

[24] Platelet activation and platelet-monocyte aggregate formation trigger tissue factor expression in patients with severe COVID-19 [J].

Hottz, Eugenio D. ;

Azevedo-Quintanilha, Isaclaudia G. ;

Palhinha, Lohanna ;

Teixeira, Livia ;

Barreto, Ester A. ;

Pao, Camila R. R. ;

Righy, Cassia ;

Franco, Sergio ;

Souza, Thiago M. L. ;

Kurtz, Pedro ;

Bozza, Fernando A. ;

Bozza, Patricia T. .

BLOOD, 2020, 136 (11) :1330-1341

[25] Re The source of elevated plasma D-dimer levels in COVID-19 infection [J].

Hunt, Beverley J. ;

Levi, Marcel .

BRITISH JOURNAL OF HAEMATOLOGY, 2020, 190 (03) :E133-E134

[26]

Ifeanyi OE, 2020, MED CLIN REV, V6, P108

[27] Antithrombotic Therapy for VTE Disease CHEST Guideline and Expert Panel Report [J].

Kearon, Clive ;

Akl, Elie A. ;

Ornelas, Joseph ;

Blaivas, Allen ;

Jimenez, David ;

Bounameaux, Henri ;

Huisman, Menno ;

King, Christopher S. ;

Morris, Timothy A. ;

Sood, Namita ;

Stevens, Scott M. ;

Vintch, Janine R. E. ;

Wells, Philip ;

Woller, Scott C. ;

Moores, Lisa .

CHEST, 2016, 149 (02) :315-352

[28] Fondaparinux pentasaccharide reduces sepsis coagulopathy and promotes survival in the baboon model of Escherichia coli sepsis [J].

Keshari, Ravi S. ;

Silasi, Robert ;

Popescu, Narcis, I ;

Georgescu, Constantin ;

Chaaban, Hala ;

Lupu, Cristina ;

McCarty, Owen J. T. ;

Esmon, Charles T. ;

Lupu, Florea .

JOURNAL OF THROMBOSIS AND HAEMOSTASIS, 2020, 18 (01) :180-190

[29] Incidence of thrombotic complications in critically ill ICU patients with COVID-19 [J].

Klok, F. A. ;

Kruip, M. J. H. A. ;

van der Meer, N. J. M. ;

Arbous, M. S. ;

Gommers, D. A. M. P. J. ;

Kant, K. M. ;

Kaptein, F. H. J. ;

Van Paassen, J. ;

Stals, M. A. M. ;

Huisman, M. V. ;

Endeman, H. .

THROMBOSIS RESEARCH, 2020, 191 :145-147

[30] COVID-19 pandemic: mechanism, diagnosis, and treatment [J].

Kumar, Vinay ;

Doshi, Khushi U. ;

Khan, Wajihul H. ;

Rathore, Anurag S. .

JOURNAL OF CHEMICAL TECHNOLOGY AND BIOTECHNOLOGY, 2021, 96 (02) :299-308

← 1 2 3 4 5 6 7 →